Molecular Excipient

87.0 -0.5 0 2 40.0 2 0.75
Present in 82 ZINC catalogs

Known Active Genes

This compound has been observed to have activity at 10μM or less against the following gene(s).
Name Description Classification
HDAC3 Histone deacetylase 3 Epigenetic Regulator / Epigenetic-E

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT01561508 2012-06-01 Effect of GABA Supplementation in the Progression of Type 1 Diabetes in Children Phase 2 Withdrawn
NCT01536483 2012-02-01 Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams Phase 2/Phase 3 Recruiting
NCT01526876 2011-11-01 The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients Phase 4 Withdrawn
NCT02173808 2011-05-01 A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception Phase 1 Completed
NCT01042574 2010-05-01 The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Phase 4 Recruiting
NCT00978822 2009-09-01 Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage Phase 2 Recruiting
NCT00917826 2008-09-01 Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies Phase 2 Terminated
NCT01567995 2008-02-01 Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety Phase 3 Completed
NCT00693693 2006-11-01 Adherence to Topical Hydrocortisone 17-Butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis Phase 4 Active, Not Recruiting
NCT00800930 2005-01-01 Therapeutic Induction of Endogenous Antibiotics Phase 2 Completed
NCT00801957 2003-03-01 Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis Phase 2 Completed
NCT00006136 1999-03-01 Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia Phase 2 Completed
NCT00004412 1997-09-01 Phase II Randomized Trial of Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers Phase 2 Recruiting
NCT00006340 1994-12-01 Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus Phase 1 Completed

(Browse) Purchasable Analogs in ZINC


Route Formulation Per Unit Dose
Transdermal Patch, Controlled Release

More Information

Usage Over Time